“…1,2 Advances include the introductions of H2 receptor antagonists, 1-3 proton pump inhibitors, 4 -7 Helicobacter pylori eradication therapies, 8,9 and evolving endoscopic approaches to treat bleeding ulcer. 10 -12 While there has clearly been an associated and dramatic decrease in the volume of elective peptic ulcer surgery, [12][13][14][15][16][17][18][19] the influences of these therapeutic advances on hospitalization and operations for peptic ulcer complications is unclear, 16,18,19 especially considering the rising proportion of emergency or urgent operations. 15,16,18,20,21 In this study, we examined the time trends of hospitalizations for PUD in the United States (US) during 1993 to 2006, focusing on the changes in ulcer site, complications, and treatment procedures over time and their effects on peptic ulcer mortality.…”